- Home
- TIL vs SGA Comparison
TIL vs SGA Comparison
Compare TIL & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TIL | SGA |
|---|---|---|
| Founded | 2018 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.7M | 78.8M |
| IPO Year | 2021 | 1992 |
Fundamental Metrics
Financial Performance| Metric | TIL | SGA |
|---|---|---|
| Price | $11.40 | $11.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $100.67 | N/A |
| AVG Volume (30 Days) | ★ 62.3K | 22.0K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 8.81% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $109,822,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.53 |
| P/E Ratio | ★ N/A | $237.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.69 | $10.75 |
| 52 Week High | $42.79 | $14.27 |
Technical Indicators
Market Signals| Indicator | TIL | SGA |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 39.67 |
| Support Level | $10.72 | $11.32 |
| Resistance Level | $11.85 | $11.95 |
| Average True Range (ATR) | 0.60 | 0.27 |
| MACD | 0.25 | -0.02 |
| Stochastic Oscillator | 60.52 | 17.81 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About SGA Saga Communications Inc. (FL)
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.